Retrospective Study of Palliative Radiotherapy in Locally Advanced and Metastatic Head and Neck Carcinoma: A Single Institution Study

Main Article Content

Narender Singh Shah
Dhiraj Daga
Deepti Singh
Manish Kumar Chaturvedi
Upen Kishor Mathur
Poonam Banthia
Ashish Kavia

Abstract

Introduction


The most common cancer of India is head and neck, and about 70% of them present in locally advanced or metastatic disease. Palliative radiotherapy is one of the commonly used treatments in such cases. A retrospective study on the outcomes and toxicity of palliative radiotherapy is studied at a tertiary centre.


Materials and Methods


In this study, 74 patients who underwent palliative radiotherapy at the tertiary centre between Nov 2017 and Oct 2019 were retrospectively analysed. The frequency of different presenting symptoms, radiotherapy regimens, their outcome in form of symptomatic relief and disease status along with toxicity was studied and analysed through the available records.   


Results


We identified 74 eligible patients. The median age was 48years (range, 26–82). Oropharyngeal primary cancer was the most common primary site. The Eastern Cooperative Oncology Group performance status was 3 or more in 74.4% patients. The radiation regimen used were ranged from 8Gyin single fraction, 20Gy in 4 fractions, 20Gy in 5 fractions, 30Gy in 10 fractions and 60Gy in 30 fractions. 93.2% of them completed their treatment. Pain and swelling were the most common presenting symptoms and 90.6% of them had more than 50% relief, while 46.5% had complete or partial response to the treatment.


Conclusion


Palliative radiotherapy to the head and neck provides some symptomatic benefit in most patients, there are multiple dose fractionation regimens currently being used for palliative radiation treatment, and consideration should be given to higher dose palliative RT regimens in patients having good performance status to maximize locoregional control and minimize late toxicity, patient with poor performance status will benefit from a hypofractionated palliative radiation treatment.

Article Details

How to Cite
1.
Shah NS, Daga D, Singh D, Chaturvedi MK, Mathur UK, Banthia P, Kavia A. Retrospective Study of Palliative Radiotherapy in Locally Advanced and Metastatic Head and Neck Carcinoma: A Single Institution Study. BJOHNS [Internet]. 2022Mar.18 [cited 2024Nov.21];29(3):231-7. Available from: https://bjohns.in/journal3/index.php/bjohns/article/view/514
Section
Main article
Author Biographies

Narender Singh Shah, JLN Medical College, Ajmer, Rajasthan

Professor, Department of Radiation Oncology, JLN Medical College and AGH, Ajmer, Rajasthan

Dhiraj Daga, JLN Medical College and AGH, Ajmer, Rajasthan

Assistant Professor, Department of Radiation Oncology, JLN Medical College and AGH, Ajmer, Rajasthan

Deepti Singh, JLN Medical College, Ajmer, Rajasthan

Department of Community Medicine, JLN Medical College, Ajmer, Rajasthan

Manish Kumar Chaturvedi, JLN Medical College, Ajmer, Rajasthan

Senior Resident, Department of Radiation Oncology, JLN Medical College and AGH, Ajmer, Rajasthan

Upen Kishor Mathur, JLN Medical College, Ajmer, Rajasthan

Senior Professor, Department of Radiation Oncology, JLN Medical College and AGH, Ajmer, Rajasthan

Poonam Banthia, Suresh Gyan Vihar University, Jaipur, Rajasthan

Research Scholar, Department of Biotechnology

Ashish Kavia, Government Medical College, Patiala Punajb

Assistant Professor, Physical Medicine and Rehabilitation, Government Medical college Patiala, 

References

Mathur P, Sathishkumar K, Chaturvedi M, Das P, Sudarshan KL, Santhappan S, et al. Cancer Statistics, 2020: Report From National Cancer Registry Programme, India. JCO Glob Oncol [Internet]. 2020 Nov;(6):1063–75. Available from: https://ascopubs.org/doi/10.1200/GO.20.00122

Amin, M.B., Edge, S., Greene, F., Byrd, D.R., Brookland, R.K., Washington, M.K., Gershenwald, J.E., Compton, C.C., Hess, K.R., Sullivan, D.C., Jessup, J.M., Brierley, J.D., Gaspar, L.E., Schilsky, R.L., Balch, C.M., Winchester, D.P., Asare, E.A., Madera, LR. AJCC Cancer Staging Manual. 8th ed. Springer International Publishing; 2017. XVII, 1032.

Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol [Internet]. 1982 Dec;5(6):649–55. Available from: http://www.ncbi.nlm.nih.gov/pubmed/7165009

Chakraborty A, Mathur SK. Rupee Scale: For Measurement Of Pain In India. Internet J Anesthesiol. 2006;12.

Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer [Internet]. 1981 Jan 1;47(1):207–14. Available from: https://onlinelibrary.wiley.com/doi/10.1002/1097-0142(19810101)47:1%3C207::AID-CNCR2820470134%3E3.0.CO;2-6

Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol [Internet]. 1982 Dec;5(6):649–56. Available from: http://journals.lww.com/00000421-198212000-00014

Kowalski LP, Carvalho AL. Natural history of untreated head and neck cancer. Eur J Cancer [Internet]. 2000 May;36(8):1032–7. Available from: https://linkinghub.elsevier.com/retrieve/pii/S095980490000054X

NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®). Palliative Care, version 2.2021. 2021;(2). Available from: https://www.nccn.org/professionals/physician_gls/pdf/palliative.pdf

Mohanti BK, Umapathy H, Bahadur S, Thakar A, Pathy S. Short course palliative radiotherapy of 20Gy in 5 fractions for advanced and incurable head and neck cancer: AIIMS study. Radiother Oncol [Internet]. 2004 Jun;71(3):275–80. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0167814004001392

Agarwal JP, Nemade B, Murthy V, Ghosh-Laskar S, Budrukkar A, Gupta T, et al. Hypofractionated, palliative radiotherapy for advanced head and neck cancer. Radiother Oncol [Internet]. 2008 Oct;89(1):51–6. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0167814008003356

Erkal HŞ, Mendenhall WM, Amdur RJ, Villaret DB, Stringer SP. Squamous cell carcinomas metastatic to cervical lymph nodes from an unknown head and neck mucosal site treated with radiation therapy with palliative intent. Radiother Oncol [Internet]. 2001 Jun;59(3):319–21. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0167814001002821

Fortin B, Khaouam N, Filion E, Nguyen-Tan PF, Bujold A, Lambert L. Palliative Radiation Therapy for Advanced Head and Neck Carcinomas: A Phase 2 Study. Int J Radiat Oncol [Internet]. 2016 Jun;95(2):647–53. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0360301616000602

Al-Mamgani A, Kessels R, Verhoef CG, Navran A, Hamming-Vrieze O, Kaanders JHAM, et al. Randomized controlled trial to identify the optimal radiotherapy scheme for palliative treatment of incurable head and neck squamous cell carcinoma. Radiother Oncol. 2020;149:181–8.

Stevens CM, Huang SH, Fung S, Bayley AJ, Cho JB, Cummings BJ, et al. Retrospective Study of Palliative Radiotherapy in Newly Diagnosed Head and Neck Carcinoma. Int J Radiat Oncol. 2011 Nov;81(4).

García-Anaya MJ, Ordoñez R, Toledo MD, Correa RC, Otero A, Román A, et al. Importance of dose in palliative treatment for incurable head and neck cancer with radiotherapy. Head Neck. 2021;43(3):798–804.

Soni A, Kaushal V, Verma M, Dhull AK, Atri R, Dhankhar R. Comparative Evaluation of Three Palliative Radiotherapy Schedules in Locally Advanced Head and Neck Cancer. World J Oncol [Internet]. 2017;8(1):7–14. Available from: http://www.wjon.org/index.php/WJON/article/view/992

Fabian A, Domschikowski J, Hoffmann M, Weiner O, Schmalz C, Dunst J, et al. Patient-Reported Outcomes Assessing the Impact of Palliative Radiotherapy on Quality of Life and Symptom Burden in Head and Neck Cancer Patients: A Systematic Review. Front Oncol. 2021;11(June):1–11.